Colin Shannon serves as Executive at PHARMACEUTICAL PRODUCT DEVELOPMENT INC, where they oversee executive responsibilities. Since joining the company, Colin Shannon has executed 68 insider transactions totaling $168.8M, demonstrating a bearish approach to their equity position. Their most recent transaction on Jul 1, 2021 involved selling 46,500 shares valued at $0.
Colin Shannon currently holds 334,595 shares of PHARMACEUTICAL PRODUCT DEVELOPMENT INC (PPDI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Colin Shannon has been a net seller of PPDI stock. They have purchased $0 and sold $168.8M worth of shares.
Colin Shannon's most recent insider trade was on Jul 1, 2021, when they sold 46,500 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $168.13 |
| Discretionary |
| Jun 17, 2021 | PRAH | $37.2M | Sale | 220,195 | $169.00 | Discretionary |
| Jun 17, 2021 | PRAH | $10.1M | Sale | 59,774 | $169.63 | Discretionary |
| Jun 17, 2021 | PRAH | $153.5K | Sale | 920 | $166.89 | Discretionary |
| Jun 17, 2021 | PRAH | $3.3M | Option Exercise | 31,780 | $103.30 | Discretionary |
| Jun 17, 2021 | PRAH | $4.6M | Option Exercise | 45,000 | $102.44 | Discretionary |
| Jun 17, 2021 | PRAH | $3.0M | Option Exercise | 31,000 | $95.94 | Discretionary |
| Jun 17, 2021 | PRAH | $6.9M | Option Exercise | 91,000 | $75.81 | Discretionary |
| Jun 17, 2021 | PRAH | $1.9M | Option Exercise | 166,036 | $11.73 | Discretionary |
| Jun 17, 2021 | PRAH | $908.2K | Option Exercise | 77,425 | $11.73 | Discretionary |
| Jun 16, 2021 | PRAH | $1.0M | Option Exercise | 88,045 | $11.73 | Discretionary |
| Jun 16, 2021 | PRAH | $687.4K | Sale | 4,104 | $167.49 | Discretionary |
| Jun 16, 2021 | PRAH | $14.0M | Sale | 83,941 | $166.44 | Discretionary |
| Jun 16, 2021 | PRAH | $1.2M | Sale | 7,132 | $166.42 | Discretionary |
| Jun 16, 2021 | PRAH | $72.3K | Sale | 430 | $168.13 | Discretionary |
| Jun 16, 2021 | PRAH | $94.4K | Sale | 564 | $167.39 | Discretionary |
| Jun 15, 2021 | PRAH | $1.6M | Option Exercise | 132,986 | $11.73 | Discretionary |
| Jun 15, 2021 | PRAH | $204.2K | Sale | 1,210 | $168.75 | Discretionary |
| Jun 15, 2021 | PRAH | $23.9M | Sale | 142,093 | $168.30 | Discretionary |
| Jun 1, 2021 | PRAH | $0 | Award | 14,486 | $N/A | Discretionary |
| Jun 1, 2021 | PRAH | $794.1K | Sale | 4,659 | $170.45 | Discretionary |
| Jun 1, 2021 | PRAH | $308.7K | Sale | 1,811 | $170.45 | Discretionary |
| Aug 13, 2020 | PRAH | $624.8K | Sale | 6,073 | $102.88 | Discretionary |
| Aug 13, 2019 | PRAH | $0 | Award | 33,000 | $N/A | Discretionary |
| Aug 16, 2018 | PRAH | $0 | Award | 30,000 | $N/A | Discretionary |
| Aug 14, 2017 | PRAH | $29.9M | Sale | 400,000 | $74.85 | Discretionary |
| Aug 8, 2017 | PRAH | $786.7K | Option Exercise | 267,579 | $2.94 | Discretionary |
| Aug 8, 2017 | PRAH | $1.6M | Option Exercise | 132,421 | $11.73 | Discretionary |
| Mar 28, 2017 | PRAH | $147.0K | Option Exercise | 50,000 | $2.94 | Discretionary |